ÂÜÀòÂÒÂ×

Qiubin Lin is the Founder & CEO of Delonix Bioworks Ltd., a company that focuses on synthetic biology to develop medical solutions for infectious diseases and cancer, with a particular emphasis on antimicrobial resistance. Prior to this role, they served as a Senior Research Officer at the HKU-Zhejiang Institute of Research and Innovation. Qiubin Lin also co-founded PreciVax Therapeutics, where they served as the COO and worked on developing innovative vaccines for drug-resistant bacterial infections. Qiubin'searlier experience includes positions as a Postdoctoral Research Fellow and Postdoctoral Research Associate at the University of Hong Kong.

Qiubin Lin completed a Bachelor of Engineering (B.Eng.) in Bioengineering at Tianjin University from 2007 to 2011. Subsequently, from 2011 to 2015, they obtained a Doctor of Philosophy (PhD) degree in Cancer Immunotherapy from The University of Hong Kong.